GlassScriptPhysician profile
Renee Gross
NPI 1164488557
$844.55
in general payments reported to CMS, 2019-2025
20 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $39.91 · 2021: $74.87 · 2022: $41.94 · 2023: $145 · 2024: $91.24 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $263.04 | 2019-2023 | |
| Exeltis, USA INC. | $66.75 | 2019-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $63.93 | 2019-2021 | |
| Pfizer INC. | $61.69 | 2019-2024 | |
| Hologic Sales and Service, LLC | $57.45 | 2019-2024 | Aptima |
| Mayne Pharma Commercial LLC | $34.77 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $34.13 | 2024-2025 | Myfembree |
| Duchesnay USA Incorporated | $29.93 | 2019 | |
| Amgen INC. | $29.86 | 2019 | |
| Radius Health, INC. | $28.02 | 2019 | |
| Daiichi Sankyo INC. | $27.17 | 2019 | |
| Astellas Pharma US INC | $25.05 | 2025 | Veozah |
| Organon LLC | $20.59 | 2025 | Jada System |
| Evofem Biosciences, INC. | $18.71 | 2025 | Solosec, Phexx, Phexxi |
| Millicent US INC | $17.07 | 2025 | Femlyv |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $15.00 | 2019 | |
| Lupin INC. | $14.70 | 2019 | |
| Boston Scientific Corporation | $12.35 | 2019 | |
| Avion Pharmaceuticals | $12.34 | 2019 | |
| Celularity INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Gross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.